nach oben

European Radiology

Erschienen in:

01.02.2008 | Breast

Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy

verfasst von: Ute Kettritz

Erschienen in: European Radiology | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

The incidence of ductal breast carcinoma in situ (DCIS) is increasing and currently lies at about 15% of all breast cancers. Detection of DCIS reduces the subsequent incidence of invasive ductal carcinoma. Patients with Breast Imaging Reporting and Data System (BI-RADS) category 4 lesions are best served by minimally invasive biopsies to improve the precision of diagnosing DCIS lesions. Vacuum-assisted biopsies have the greatest sensitivity and specificity of the biopsy techniques and reduce tumor upgrading of DCIS lesions at operation by at least half compared with core-needle biopsy. Moreover, vacuum-assisted biopsies have proved to be safe and reduce health care costs. Since they provide a maximum of preoperative information, vacuum-assisted biopsies could improve outcomes in patients with DCIS.

Winchester DP, Strom EA (1998) Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 48:108–128PubMedCrossRef

Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160:953–958PubMedCrossRef

Feig SA (2000) Ductal carcinoma in situ. Implications for screening mammography. Radiol Clin North Am 38:653–668, viiPubMedCrossRef

Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 56:814–819PubMed

Pollei SR, Mettler FA Jr, Bartow SA, Moradian G, Moskowitz M (1987) Occult breast cancer: prevalence and radiographic detectability. Radiology 163:459–462PubMed

Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796–807PubMedCrossRef

Kopans DB, Rafferty E, Georgian-Smith D et al (2003) A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena. Cancer 97:2951–2959PubMedCrossRef

Boecker W, Buerger H (2003) Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept. Cell Prolif 36(Suppl 1):73–84PubMedCrossRef

Boecker W (2006) Preneoplasia of the breast. Elsevier Saunders, Munich

10.

Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM (2004) Ductal carcinoma in situ of the breast. N Engl J Med 350:1430–1441PubMedCrossRef

11.

Gallager HS, Martin JE, Moore DL, Paulus DD (1979) The detection and diagnosis of early occult and minimal breast cancer. Curr Probl Cancer 3:1–32PubMedCrossRef

12.

Betsill WL, Rosen PP, Lieberman PH et al (1978) Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 239:1863–1867PubMedCrossRef

13.

Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76:1197–1200PubMedCrossRef

14.

Silverstein MJ, Poller DN, Waisman JR et al (1995) Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154–1157PubMedCrossRef

15.

Bijker N, Meijnen P, Peterse JL et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381–3387PubMedCrossRef

16.

Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231–273PubMed

17.

Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH (1990) Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335:519–522PubMedCrossRef

18.

Lagios MD (1990) Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 70:853–871PubMed

19.

Ohtake T, Kimijima I, Fukushima T et al (2001) Computer-assisted complete three-dimensional reconstruction of the mammary ductal/lobular systems: implications of ductal anastomoses for breast-conserving surgery. Cancer 91:2263–2272PubMedCrossRef

20.

Faverly DR, Burgers L, Bult P, Holland R (1994) Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11:193–198PubMed

21.

Tavassoli FA (1999) Pathology of the breast. McGraw-Hill, New York

22.

Holland R, Peterse JL, Millis RR et al (1994) Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 11:167–180PubMed

23.

Sloane JP, Amendoeira I, Apostolikas N et al (1998) Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European commission working group on breast screening pathology. Hum Pathol 29:1056–1062PubMed

24.

Lagios MD, Margolin FR, Westdahl PR, Rose MR (1989) Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618–624PubMedCrossRef

25.

Solin LJ, Yeh IT, Kurtz J et al (1993) Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 71:2532–2542PubMedCrossRef

26.

Silverstein MJ, Lagios MD, Craig PH et al (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267–2274PubMedCrossRef

27.

Evans AJ, Pinder S, Ellis IO et al (1994) Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. Radiology 191:237–240PubMed

28.

Stomper PC, Connolly JL, Meyer JE, Harris JR (1989) Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 172:235–241PubMed

29.

Holland R, Hendriks JH (1994) Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 11:181–192PubMed

30.

Morakkabati-Spitz N, Leutner C, Schild H, Traeber F, Kuhl C (2005) Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol 15:2010–2017PubMedCrossRef

31.

Oshida K, Nagashima T, Ueda T et al (2005) Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. Eur Radiol 15:1353–1360PubMedCrossRef

32.

Leinsinger G, Schlossbauer T, Scherr M, Lange O, Reiser M, Wismuller A (2006) Cluster analysis of signal-intensity time course in dynamic breast MRI: does unsupervised vector quantization help to evaluate small mammographic lesions? Eur Radiol 16:1138–1146PubMedCrossRef

33.

Schouten van der Velden AP, Boetes C, Bult P, Wobbes T (2006) The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 192:172–178PubMedCrossRef

34.

Kettritz U, Morack G, Decker T (2005) Stereotactic vacuum-assisted breast biopsies in 500 women with microcalcifications: radiological and pathological correlations. Eur J Radiol 55:270–276PubMedCrossRef

35.

American College of Radiology (2003) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas), 4th edn. American College of Radiology, Reston

36.

Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD (1998) The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol 171:35–40PubMed

37.

Fondrinier E, Lorimier G, Guerin-Boblet V, Bertrand AF, Mayras C, Dauver N (2002) Breast microcalcifications: multivariate analysis of radiologic and clinical factors for carcinoma. World J Surg 26:290–296.PubMedCrossRef

38.

Evans A, Pinder S, Wilson R et al (1994) Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol 162:1307–1311PubMed

39.

Jackman RJ, Marzoni FA Jr (1997) Needle-localized breast biopsy: why do we fail? Radiology 204:677–684PubMed

40.

Abrahamson PE, Dunlap LA, Amamoo MA, Schell MJ, Braeuning MP, Pisano ED (2003) Factors predicting successful needle-localized breast biopsy. Acad Radiol 10:601–606PubMedCrossRef

41.

Rissanen TJ, Makarainen HP, Mattila SI et al (1993) Wire localized biopsy of breast lesions: a review of 425 cases found in screening or clinical mammography. Clin Radiol 47:14–22PubMedCrossRef

42.

Liberman L, LaTrenta LR, Dershaw DD et al (1997) Impact of core biopsy on the surgical management of impalpable breast cancer. AJR Am J Roentgenol 168:495–499PubMed

43.

Gundry KR, Berg WA (1998) Treatment issues and core needle breast biopsy: clinical context. AJR Am J Roentgenol 171:41–49PubMed

44.

Verkooijen HM, Borel Rinkes IH, Peeters PH et al (2001) Impact of stereotactic large-core needle biopsy on diagnosis and surgical treatment of nonpalpable breast cancer. Eur J Surg Oncol 27:244–249PubMedCrossRef

45.

Pisano ED, Fajardo LL, Tsimikas J et al (1998) Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The radiologic diagnostic oncology group 5 study. The RDOG5 investigators. Cancer 82:679–688PubMedCrossRef

46.

Parker SH, Burbank F, Jackman RJ et al (1994) Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 193:359–364PubMed

47.

Verkooijen HM (2002) Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 99:853–859PubMedCrossRef

48.

Schulz-Wendtland R, Kramer S, Lang N, Bautz W (1998) Ultrasonic guided microbiopsy in mammary diagnosis: indications, technique and results. Anticancer Res 18:2145–2146PubMed

49.

Brenner RJ, Fajardo L, Fisher PR et al (1996) Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. AJR Am J Roentgenol 341–346

50.

Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH (1999) Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol 172:683–687PubMed

51.

Jackman RJ, Rodriguez-Soto J (2006) Breast microcalcifications: retrieval failure at prone stereotactic core and vacuum breast biopsy—frequency, causes, and outcome. Radiology 239:61–70PubMedCrossRef

52.

Burbank F, Parker SH, Fogarty TJ (1996) Stereotactic breast biopsy: improved tissue harvesting with the Mammotome. Am Surg 738–744.

53.

Parker SH, Klaus AJ (1997) Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. Radiographics 17:1233–1252PubMed

54.

Meyer JE, Smith DN, DiPiro PJ et al (1997) Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device. Radiology 204:575–576PubMed

55.

Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP (1998) Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology 208:251–260PubMed

56.

Stomper PC, Margolin FR (1994) Ductal carcinoma in situ: the mammographer’s perspective. AJR Am J Roentgenol 162:585–591PubMed

57.

Kettritz U, Rotter K, Schreer I et al (2004) Stereotactic vacuum-assisted breast biopsy in 2874 patients. Cancer 100:245–251PubMedCrossRef

58.

Heywang-Kobrunner SH, Schreer I, Decker T, Böcker W (2003) Interdisciplinary consensus on the use and technique of vacuum assisted stereotactic breast biopsy. Eur J Radiol 47:232–236PubMedCrossRef

59.

Silverstein MJ, Lagios MD, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461PubMedCrossRef

60.

Silverstein MJ, Barth A, Poller DN et al (1995) Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31A:1425–1427PubMedCrossRef

61.

Tunon-de-Lara C, de-Mascarel I, Mac-Grogan G et al (2001) Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment-the experience of one institute. Am J Clin Oncol 24:531–536PubMedCrossRef

62.

Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol 16:441–452PubMed

63.

Julien JP, Bijker N, Fentiman IS et al (2000) Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528–533PubMedCrossRef

64.

Mokbel K, Cutuli B (2006) Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol 7:756–765PubMedCrossRef

65.

Moran CJ, Kell MR, Flanagan FL, Kennedy M, Gorey TF, Kerin MJ (2007) Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Am J Surg 194:172–175PubMedCrossRef

66.

Darling ML, Smith DN, Lester SC et al (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 175:1341–1346PubMed

67.

Won B, Reynolds HE, Lazaridis CL, Jackson VP (1999) Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. AJR Am J Roentgenol 173:227–229PubMed

68.

Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP (1995) Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 164:1111–1113PubMed

69.

Jackman RJ, Burbank F, Parker SH et al (2001) Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218:497–502PubMed

Titel: Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy
verfasst von: Ute Kettritz
Publikationsdatum: 01.02.2008
Verlag: Springer-Verlag
Erschienen in: European Radiology / Ausgabe 2/2008
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-007-0753-4

Neu im Fachgebiet Radiologie

08.04.2024 | Andrologie | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy

Abstract

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

Variability of repeated coronary artery calcium measurements by 1.25-mm- and 2.5-mm-thickness images on prospective electrocardiograph-triggered 64-slice CT

Percutaneous treatment of symptomatic non-parasitic benign liver cysts: Single-session alcohol sclerotherapy versus prolonged catheter drainage with negative pressure

MR classification of renal masses with pathologic correlation

Percutaneous treatment of symptomatic non-parasitic benign liver cysts: Single-session alcohol sclerotherapy versus prolonged catheter drainage with negative pressure

ECG-gated chest CT angiography with 64-MDCT and tri-phasic IV contrast administration regimen in patients with acute non-specific chest pain

A possible cause of multiple intramuscular masses: Mazabraud’s syndrome (2007: 11b)

Neu im Fachgebiet Radiologie

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Studie bestätigt Potenzial von KI in der Radiologie

Quantitative Angiografie könnte IVUS-Alternative darstellen

Die Ganz-Genom-Sequenzierung startet

Update Radiologie